rivaroxaban우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42559699
Comparative effectiveness and safety of apixaban vs. rivaroxaban in patients with cirrhosis and portal vein thrombosis.
Comparative effectiveness and safety of apixaban vs. rivaroxaban in patients with cirrhosis and portal vein thrombosis.
- 저자
- Lucy S Wang, Adam Cuker, K Rajender Reddy, Ghadeer K Dawwas
- 저널
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- 공개일
- 2026 Aug 06
- 연구 유형
- 기타
- DOI
- 10.1097/MBC.0000000000001446
문헌 요약
Portal vein thrombosis (PVT) occurs in ~14% of patients with cirrhosis. Although apixaban and rivaroxaban are increasingly used in this population, comparative data are lacking. We conducted a retrospective cohort study of adults with cirrhosis and PVT initiating apixaban or rivaroxaban. Propensity score matching (3 : 1) was used to balance baseline chara…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.